150 related articles for article (PubMed ID: 9300369)
1. A case of a pony with Cushing's disease.
Okada T; Yuguchi K; Kiso Y; Morikawa Y; Nambo Y; Oikawa M; Sasaki F
J Vet Med Sci; 1997 Aug; 59(8):707-10. PubMed ID: 9300369
[TBL] [Abstract][Full Text] [Related]
2. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
Orth DN; Nicholson WE
Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
[TBL] [Abstract][Full Text] [Related]
3. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
4. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.
Moore JN; Steiss J; Nicholson WE; Orth DN
Endocrinology; 1979 Mar; 104(3):576-82. PubMed ID: 220013
[TBL] [Abstract][Full Text] [Related]
5. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
6. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
7. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.
Orth DN; Holscher MA; Wilson MG; Nicholson WE; Plue RE; Mount CD
Endocrinology; 1982 Apr; 110(4):1430-41. PubMed ID: 6277607
[No Abstract] [Full Text] [Related]
8. [Anorexia in a pony with Cushing's disease].
van der Kolk JH; van Hoorn CJ; van Garderen E; van den Belt AJ
Tijdschr Diergeneeskd; 1993 May; 118(9):298-300. PubMed ID: 8387700
[TBL] [Abstract][Full Text] [Related]
9. [A horse with Cushing's disease].
van der Kolk JH; Klein WR; van der Putten SW; Mol JA
Tijdschr Diergeneeskd; 1991 Jul; 116(13):670-5. PubMed ID: 1650504
[TBL] [Abstract][Full Text] [Related]
10. [Equine Cushing syndrome (ECS). Case report, review of its diagnosis and therapy and substantial differences from Cushing syndrome in dogs].
Fey K; Jonigkeit E; Moritz A
Tierarztl Prax Ausg G Grosstiere Nutztiere; 1998 Feb; 26(1):41-7. PubMed ID: 9626747
[TBL] [Abstract][Full Text] [Related]
11. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
Krieger DT; Allen W
J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
[TBL] [Abstract][Full Text] [Related]
12. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
13. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
[TBL] [Abstract][Full Text] [Related]
14. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
15. TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism.
Pijnacker T; Knies M; Galac S; Sanders K; Mol JA; Kooistra HS
Vet Q; 2018 Dec; 38(1):72-78. PubMed ID: 30362899
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
[TBL] [Abstract][Full Text] [Related]
17. [ACTH-independent Cushing's syndrome due to bilateral macronodular adrenal hyperplasia with empty sella turcica and anterior panhypopituitarism].
Menéndez Torre EL; López Carballo MT; Rodríguez Erdozain R; Urbieta Echezarreta M; Lafita Tejedor J; Forga Llenas L
Rev Clin Esp; 1992 Mar; 190(5):261-3. PubMed ID: 1315980
[TBL] [Abstract][Full Text] [Related]
18. Equine Cushing's disease.
Love S
Br Vet J; 1993; 149(2):139-53. PubMed ID: 8485640
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
20. Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary.
Millington WR; Dybdal NO; Dawson R; Manzini C; Mueller GP
Endocrinology; 1988 Sep; 123(3):1598-604. PubMed ID: 2456916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
